Author:
Cao Qijun,Wang Haixia,Zhu Jialong,Qi Chen,Huang Hairong,Chu Xiaoyuan
Publisher
China Science Publishing & Media Ltd.
Subject
General Medicine,Biochemistry,Biophysics,Molecular Biology
Reference46 articles.
1. Lambe G, Durand M, Buckley A, Nicholson S, McDermott R. Adenocarcinoma of the lung: from BAC to the future. Insights Imag, 2020, 11:
2. Succony L, Rassl DM, Barker AP, McCaughan FM, Rintoul RC. Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies. Cancer Treatment Rev, 2021, 99:
3. Kuhn E, Morbini P, Cancellieri A, Damiani S, Cavazza A, Comin CE: Adenocarcinoma classification: patterns and prognosis. Pathologica 2018, 110: 5–11.
4. Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis, 2018, 9:
5. Liu Y, Li Y, Wang X, Liu F, Gao P, Quinn MM, Li F. Gemcitabine and Chk1 inhibitor AZD7762 synergistically suppress the growth of Lkb1-deficient lung adenocarcinoma. Cancer Res, 2017, 77: 5068-5076.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献